Blend · Pen
Glow Blend
$19970mg
A three-peptide blend for laboratory research into tissue repair, skin biology and connective-tissue signalling.
EternaGen / Research use onlyBlend · Research use only
CJC-1295 + Ipamorelin
From CA$129CAD
A two-peptide blend used to explore how different signals influence the body’s growth-hormone system.
Available to approved purchasers
Select strength
1
Documentation review pending Fulfilled in Canada Research use only
Can’t find the right record?Send support the product name or batch code.
Contact supportProduct information
CJC-1295 + Ipamorelin, clearly explained.
A two-peptide blend used to explore how different signals influence the body’s growth-hormone system.
Overview
CJC-1295 and ipamorelin influence growth-hormone signalling through different pathways. Each has some early human research, but the combination, its long-term effects and meaningful health outcomes have not been established.
CJC-1295 is a long-acting analogue of growth-hormone-releasing hormone. Ipamorelin is a ghrelin-receptor agonist and growth-hormone secretagogue. Evidence for each molecule must be kept separate from evidence for the fixed blend.- Format
- Vial
- Available strengths
- 10mg · 20mg
- Documentation
- Source review pending
Research at a glanceLimited early human evidence for the individual compounds; combination not established
Reviewed 23 July 2026View research context Specifications
Product details
- Storage and handling
- Follow the handling conditions listed on the Certificate of Analysis and physical label.
Batch documentationSource review pending
Not yet publishedSupplier-origin documentation will be published only after EternaGen verifies the source and record details.
Important research-use boundary
Health Canada lists the named compound or components among unauthorized injectable drugs identified in the Canadian market. A research-use label does not make an unauthorized product suitable or legal for personal use.
Explore the research
What has been studied?
Keep the context attached
Check what was studied, what researchers observed, and the limitation attached to each finding.
Question 01
Growth-hormone and IGF-I response
Short CJC-1295 studies in healthy adults measured pharmacokinetics and sustained changes in circulating growth hormone and IGF-I.
Evidence so far: Early human pharmacologyQuestion 02
Gastrointestinal motility
A phase 2 ipamorelin trial after bowel resection studied time to a standardized meal and found no significant difference on key or secondary efficacy analyses.
Evidence so far: Negative proof-of-concept trialQuestion 03
The fixed combination
The individual studies do not test this CJC-1295 plus ipamorelin blend, its ratio, or long-term clinical outcomes.
Evidence so far: Combination evidence gapProposed mechanism
How researchers are investigating the mechanism.
CJC-1295 and ipamorelin act through different receptors upstream of growth-hormone signalling. Measuring growth hormone or IGF-I shows pharmacodynamic activity; it does not by itself establish a meaningful health outcome.
Evidence gaps
What remains unknown?
- No well-controlled clinical evidence was identified for the fixed CJC-1295 plus ipamorelin combination.
- Long-term endocrine, metabolic and cardiovascular outcomes for the combination are not established.
- Different CJC-1295 forms are not automatically interchangeable; molecular identity and formulation matter.
Primary sources
Check the original sources.
- Primary CJC-1295 studyTeichman et al. Randomized healthy-adult pharmacology studies. J Clin Endocrinol Metab. 2006. PMID 16352683.
- Primary ipamorelin studyBeck et al. Postoperative phase 2 proof-of-concept trial. Int J Colorectal Dis. 2014. PMID 25331030.
- Regulatory safety reviewU.S. FDA. Safety considerations for CJC-1295 and ipamorelin-related bulk substances.
Related products
Continue comparing.
Blend · Vial
Klow Blend
$21980mg
A four-peptide blend for laboratory research spanning tissue, skin and inflammatory-signalling models.
Blend · Vial
20mg
A two-peptide blend of Semax and Selank (10mg each), explored in neuroscience research.